WebDelisting of the Company's shares from Securities listed at PT. Bursa Efek Indonesia (Delisting) 2. Details of Material Information. Delistings made to all Company's shares … WebThe corporate group of Taisho consists of Taisho, twenty-five (25) subsidiary companies and three (3) affiliated companies, and the major businesses of the Taisho group consist of research, development, manufacture and sale of OTC drugs, foods for special health use, foods, pharmaceutical products, and sanitary products (Self-Medication Operation …
Taisho Pharmaceutical Holdings Co., Ltd. - Nikkei Asia
WebThe company's principal line of business is over-the-counter (OTC) medicines, where it markets the brands Lipovitan-D, Pabron, Colac, Contac, Tempra, UPSA, Vicks and Kampo … WebTaisho Pharmaceutical Indonesia is a Drug Manufacturing & Research, Pharmaceuticals, and Healthcare company located in Tokyo, Tokyo with $2.49 Billion in revenue and 263 employees. Find top employees, contact details and business statistics at RocketReach. imagine foster the people
News Taisho Pharmaceutical Holdings
Web26 Jun 2024 · Berdasarkan Peraturan BEI Nomor I-I tentang Penghapusan Pencatatan (delisting) dan Pencatatan Kembali (relisting), disebutkan salah satu syarat delisting … WebIndonesia PT. Taisho Pharmaceutical Indonesia Tbk. Location: Jakarta, Indonesia Business Area: Manufacture and sale of pharmaceuticals. Singapore Taisho Pharmaceutical Singapore Private Limited. Location: Singapore Business Area: Generalization of OTC drug business in the ASEAN region. WebTaisho Pharmaceutical Holdings acquired the commercial rights to Tempra® in 2009 from Bristol-Myers Squibb. Today, the Tempra® brand is one of the biggest in Taisho’s … imagine freedom